Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2026-05-23 @ 10:02 AM
Study NCT ID:
NCT05808335
Status:
UNKNOWN
Last Update Posted:
2023-06-15
First Post:
2023-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)
Sponsor:
ImmuneMed, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Hepatitis B | View |
Keywords: